Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Lysosomal Acid Lipase Deficiency (LAAL) Treatment
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market by Type

• 3.1 By Type
  • 3.1.1 Enzyme Replacement Therapy
  • 3.1.2 Kidney Transplantation
  • 3.1.3 Stem Cell Transplantation
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Lysosomal Acid Lipase Deficiency (LAAL) Treatment AstraZeneca plc (Company Profile, Sales Data etc.)

• 4.2 Merck & Co., Inc (Company Profile, Sales Data etc.)
• 4.3 Pfizer, Inc. (Company Profile, Sales Data etc.)
• 4.4 Alexion Pharmaceutical Inc (Company Profile, Sales Data etc.)
• 4.5 Lonza Group Ltd. (Company Profile, Sales Data etc.)
• 4.6 hermo Fisher Scientific (Company Profile, Sales Data etc.)
• 4.7 Teva Pharmaceutical Industries Ltd. (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Wolman Disease
  • 6.1.2 Demand in Cholesterol Ester Storage Disease (CESD)
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Lysosomal Acid Lipase Deficiency (LAAL) Treatment

Table Application Segment of Lysosomal Acid Lipase Deficiency (LAAL) Treatment

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market 2013-2024, by Application, in USD Million

Table Major Company List of Enzyme Replacement Therapy

Table Major Company List of Kidney Transplantation

Table Major Company List of Stem Cell Transplantation

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market 2013-2018, by Type, in USD Million

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market 2013-2018, by Type, in Volume

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Forecast 2019-2024, by Type, in USD Million

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Forecast 2019-2024, by Type, in Volume

Table AstraZeneca plc Overview List

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of AstraZeneca plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck & Co., Inc Overview List

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of Merck & Co., Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer, Inc. Overview List

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Alexion Pharmaceutical Inc Overview List

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of Alexion Pharmaceutical Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Lonza Group Ltd. Overview List

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of Lonza Group Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table hermo Fisher Scientific Overview List

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of hermo Fisher Scientific (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Pharmaceutical Industries Ltd. Overview List

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of Teva Pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Sales Revenue 2013-2018, by Company, in USD Million

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Sales Revenue Share, by Company, in USD Million

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Sales Volume 2013-2018, by Company, in Volume

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Demand Forecast 2019-2024, by Application, in USD Million

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Demand Forecast 2019-2024, by Application, in Volume

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Production 2013-2018, by Region, in USD Million

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Production 2013-2018, by Region, in Volume

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market 2013-2018, by Region, in USD Million

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share 2013-2018, by Region, in USD Million

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market 2013-2018, by Region, in Volume

Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share 2013-2018, by Region, in Volume

Table North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in USD Million

Table North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in Volume

Table Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in USD Million

Table Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in Volume

Table South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in USD Million

Table South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in Volume

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Forecast 2019-2024, by Region, in USD Million

Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Growth 2013-2018, by Type, in USD Million

Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Growth 2013-2018, by Type, in Volume

Figure North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Concentration, in 2018

Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Market Concentration, in 2018

Figure Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment MMarket Concentration, in 2018

Figure South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Concentration, in 2018

Figure Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Concentration, in 2018

Figure Lysosomal Acid Lipase Deficiency (LAAL) Treatment Demand in Wolman Disease, 2013-2018, in USD Million

Figure Lysosomal Acid Lipase Deficiency (LAAL) Treatment Demand in Wolman Disease, 2013-2018, in Volume

Figure Lysosomal Acid Lipase Deficiency (LAAL) Treatment Demand in Cholesterol Ester Storage Disease (CESD), 2013-2018, in USD Million

Figure Lysosomal Acid Lipase Deficiency (LAAL) Treatment Demand in Cholesterol Ester Storage Disease (CESD), 2013-2018, in Volume

Figure North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in USD Million

Figure North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in Volume

Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in USD Million

Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in Volume

Figure South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in USD Million

Figure South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview